Pfizer says obesity injection shows promise as monthly treatment in mid-stage trial

The data on Pfizer's GLP-1 offer early evidence that the injection can be administered less frequently than existing drugs ...

Healthy Returns: Pfizer execs chart out obesity strategy after encouraging drug data

Pfizer made one thing clear this week: It's officially back in the obesity race.
MM&M

Pfizer’s birth control injection has a new safety label, reflecting potential brain tumors

Pfizer’s battle over the safety label for its birth control injection has finally come to a close. The pharma giant announced that the Food and Drug Administration approved its new safety warning ...

Pfizer maps post-Covid reset with obesity trials and deep cost cuts

Pfizer beat fourth-quarter estimates as Covid sales fell, pointing to obesity trial progress and cost cuts in its post-Covid ...